Download PDF
Exp Clin Endocrinol Diabetes 2005; 113(2): 85-89
DOI: 10.1055/s-2005-837510
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Coincidence of High Antiislet and Antithyroid Autoantibody Titles in First-Degree Relatives of Patients with Type 1 Diabetes

F. Sougioultzoglou1 , A. Falorni2 , G. Kassi2 , A. Brozzetti2 , D. Karamitsos1 , G. G. Koliakos3
  • 1Diabetes Center, Hippokratio Hospital, Medical School, Aristotle University, Thessaloniki, Greece
  • 2Department of Internal Medicine, Section of Internal Medicine and Endocrine & Metabolic Sciences, University of Perugia, Perugia, Italy
  • 3Department of Biological Chemistry, Medical School, Aristotle University, Thessaloniki, Greece
Further Information

Publication History

Received: January 16, 2004 First decision: May 6, 2004

Accepted: November 16, 2004

Publication Date:
17 March 2005 (online)

Also available at
    Permissions and Reprints

Abstract

An association between thyroid and islet autoantibodies has been reported for patients with type 1 diabetes and their first-degree relatives. However no general agreement on this association has been reached since several studies reported controversial data. In the present study, sera from 429 healthy first-degree relatives of type 1 diabetic patients have been examined for the presence of thyroid and islet autoantibodies. Autoantibodies against glutamate decarboxylase (GAD65Ab) and tyrosine-phosphatase IA-2 (IA-2/ICA512Ab) have been detected by radioimmunoassay techniques with in vitro translated recombinant human 35S-autoantigens. The presence of autoantibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) has been estimated by commercial radioimmunoassay kits. An increased frequency of TgAb was found in subjects who were positive for GAD65Ab (p = 0.0257). However, no significant association between TPOAb and GAD65Ab or IA-2Ab or between TgAb and IA-2Ab could be established. These data indicate an increased rate of coincidence between TgAb and GAD65Ab in healthy first-degree relatives of type 1 diabetic patients. Accordingly a common genetic background leading to the appearance of both TgAb and GAD65Ab may be suggested.

Key words

Type 1 diabetes - autoimmunity - thyroid - GAD65 antibodies - IA-2 antibodies

References

  • 1 Abraham R S, Wen L, Marietta E V, David C S. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.  J Immunol. 2001;  166 1370-1379
    PubMedGoogle Scholar
  • 2 Baekkeskov S, Landin M, Kristensen J K, Srikanta S, Bruining G J, Mandrup-Poulsen T, de Beaufort C, Soeldner J S, Eisenbarth G, Lindgren F. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.  J Clin Invest. 1987;  79 926-934
    PubMedGoogle Scholar
  • 3 Betterle C, Zanette F, Pedini B, Presotto F, Rapp L B, Monciotti C M, Rigon F. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives.  Diabetologia. 1984;  26 431-436
    PubMedGoogle Scholar
  • 4 Bingley P J, Christie M R, Bonifacio E, Bonfanti R, Shattock M, Fonte M T, Bottazzo G F, Gale E A. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.  Diabetes. 1994;  43 1304-1310
    PubMedGoogle Scholar
  • 5 Chang C C, Huang C N, Chuang L M. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan.  Eur J Endocrinol. 1998;  139 44-48
    CrossrefPubMedGoogle Scholar
  • 6 Chen B H, Chung S B, Chiang W, Chao M C. GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus.  Diabetes Res Clin Pract. 2001;  54 27-32
    CrossrefPubMedGoogle Scholar
  • 7 De Block C E, De Leeuw I H, Decochez K, Winnock F, Van Autreve J, Van Campenhout C M, Martin M, Gorus F K. The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status.  J Clin Endocrinol Metab. 2001;  86 4358-4363
    CrossrefPubMedGoogle Scholar
  • 8 Estienne V, Duthoit C, Costanzo V D, Lejeune P J, Rotondi M, Kornfeld S, Finke R, Lazarus J H, Feldt-Rasmussen U, Franke W G, Smyth P, D'Herbomez M, Conte-Devolx B, Persani L, Carella C, Jourdain J R, Izembart M, Toubert M E, Pinchera A, Weetman A, Sapin R, Carayon P, Ruf J. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters.  Eur J Endocrinol. 1999;  141 563-569
    CrossrefPubMedGoogle Scholar
  • 9 Falorni A, Ortqvist E, Persson B, Lernmark A. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands.  J Immunol Methods. 1995;  186 89-99
    CrossrefPubMedGoogle Scholar
  • 10 Feldt-Rasmussen U, Hoier-Madsen M, Bech K, Blichert-Toft M, Bliddal H, Date J, Danneskiold-Samsoe B, Hegedus L, Hippe E, Hornnes P J. Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases.  Autoimmunity. 1991;  9 245-254
    CrossrefPubMedGoogle Scholar
  • 11 Fialkow P J, Zavala C, Nielsen R. Thyroid autoimmunity: increased frequency in relatives of insulin-dependent diabetes patients.  Ann Intern Med. 1975;  83 170-176
    PubMedGoogle Scholar
  • 13 Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM.  Diabetologia. 1996;  39 1223-1226
    PubMedGoogle Scholar
  • 14 Gorus F K, Goubert P, Semakula C, Vandewalle C L, De Schepper J, Scheen A, Christie M R, Pipeleers D G. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings; The Belgian Diabetes Registry.  Diabetologia. 1997;  40 95-99
    CrossrefPubMedGoogle Scholar
  • 15 Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum W A, Federlin K, Bretzel R G. The combination of antibodies to GAD-65 and IA-1 c can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.  Horm Metab Res. 1999;  10 564-569
    PubMedGoogle Scholar
  • 16 Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel R G. Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.  Diabetes Care. 2001;  24 27-32
    PubMedGoogle Scholar
  • 17 Karlsen A E, Hagopian W A, Grubin C E, Dube S, Disteche C M, Adler D A, Barmeier H, Mathewes S, Grant F J, Foster D, Lernmark A. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.  Proc Natl Acad Sci USA. 1991;  88 8337-8342
    PubMedGoogle Scholar
  • 18 Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.  Diabetes. 1994;  43 80-86
    CrossrefPubMedGoogle Scholar
  • 19 Kulmala P, Savola K, Petersen J S, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom H K, Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.  J Clin Invest. 1998;  101 327-336
    PubMedGoogle Scholar
  • 20 Kurkeja A, Balducci-Silano P, Maclaren N. Association between immune-mediated (type-1) diabetes mellitus and other autoimmune diseases. LeRoith D, Taylor SI, Olefsky JM Diabetes Mellitus. Fundamental Clinical Text. Philadelphia, USA; Lippincott-Raven 2000: 412-436
    Google Scholar
  • 21 Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G. Islet and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children,.  Diabetologia. 1989;  32 387-395
    CrossrefPubMedGoogle Scholar
  • 22 Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She J X, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander A, Vegt P, Notkins A, Krischer J. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2 beta predict immune-mediated (Type 1) diabetes in relatives.  J Autoimmun. 1999;  12 279-287
    CrossrefPubMedGoogle Scholar
  • 23 Martino G V, Tappaz M L, Braghi S, Dozio N, Canal N, Pozza G, Bottazzo G F, Grimaldi L M, Bosi E. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.  J Autoimmun. 1991;  4 915-923
    CrossrefPubMedGoogle Scholar
  • 24 Maugendre D, Guilhem I, Karacatsanis C, Poirier J Y, Leguerrier A M, Lorcy Y, Derrien C, Sonnet E, Massart C. Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients.  Ann Endocrinol (Paris). 2000;  61 524-530
    PubMedGoogle Scholar
  • 25 Maugendre D, Massart C, Karacatsanis C, Guilhem I, Poirier J Y, Sonnet E, Allannic H. Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone.  Diabetes Metab. 1997;  23 302-307
    PubMedGoogle Scholar
  • 26 Pastore M R, Bazzigaluppi E, Bonfanti R, Dozio N, Sergi A, Balini A, Belloni C, Meschi F, Bonifacio E, Bosi E. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.  Diabetes Care. 1998;  21 1445-1450
    CrossrefPubMedGoogle Scholar
  • 27 Payami H, Joe S, Thomson G. Autoimmune thyroid disease in type I diabetic families.  Genet Epidemiol. 1989;  6 137-141
    CrossrefPubMedGoogle Scholar
  • 28 Rattarasarn C, Diosdado M A, Ortego J, Leelawattana R, Soonthornpun S, Setasuban W, Jaruratanasirikul S, Patarakijvanich N. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.  Diabetes Res Clin Pract. 2000;  49 107-111
    CrossrefPubMedGoogle Scholar
  • 29 Roll U, Christie M R, Fuchtenbusch M, Payton M A, Hawkes C J, Ziegler A G. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.  Diabetes. 1996;  45 967-973
    PubMedGoogle Scholar
  • 30 Roman S H, Davies T F, Witt M E, Ginsberg-Fellner F, Rubinstein P. Thyroid autoantibodies in HLA-genotyped type 1 diabetic families: sex-limited DR5 association with thyroid microsomal antibody.  Clin Endocrinol (Oxf). 1986;  25 23-33
    PubMedGoogle Scholar
  • 31 Rowley M J, Mackay I R, Chen Q Y, Knowles W J, Zimmet P Z. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus.  Diabetes. 1992;  41 548-551
    PubMedGoogle Scholar
  • 32 Seissler J, Morgenthaler N G, Achenbach P, Lampeter E F, Glawe D, Payton M, Christie M, Scherbaum W A. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.  Diabetologia. 1996;  39 1351-1356
    CrossrefPubMedGoogle Scholar
  • 33 Smithson M J. Screening for thyroid dysfunction in a community population of diabetic patients.  Diabet Med. 1998;  15 148-150
    CrossrefPubMedGoogle Scholar
  • 34 Vandewalle C L, Decraene T, Schuit F C, De Leeuw I H, Pipeleers D G, Gorus F K. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.  Diabetologia. 1993;  36 1155-1162
    CrossrefPubMedGoogle Scholar
  • 35 Vandewalle C L, Falorni A, Svanholm S, Lernmark A, Pipeleers D G, Gorus F K. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry.  J Clin Endocrinol Metab. 1995;  80 846-851
    CrossrefPubMedGoogle Scholar
  • 36 Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson R A, Chase H P, Eisenbarth G S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512 bdc/IA-2 autoantibodies.  Diabetes. 1996;  45 926-933
    CrossrefPubMedGoogle Scholar
  • 37 Verge C F, Howard N J, Rowley M J, Mackay I R, Zimmet P Z, Egan M, Hulinska H, Hulinsky I, Silvestrini R A, Kamath S. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.  Diabetologia. 1994;  37 1113-1120
    CrossrefPubMedGoogle Scholar
  • 38 Verge C F, Stenger D, Bonifacio E, Colman P G, Pilcher C, Bingley P J, Eisenbarth G S. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type 1 diabetes. Combinatorial islet autoantibody workshop.  Diabetes. 1998;  47 1857-1866
    CrossrefPubMedGoogle Scholar

George Koliakos

PO Box 17034

54210 Thessaloniki

Greece

Phone: + 302310999123

Fax: + 30 23 10 99 90 04

Email: koliakos@med.auth.gr

      >